This video shares the inspiring journey of Suma Krishnan, a biotech entrepreneur who, at age 51, envisioned a groundbreaking topical gene therapy for a severe skin disorder called dystrophic epidermolysis bullosa. She co-founded Krystal Biotech without venture capital, choosing risk and boldness over traditional funding. Under her leadership, the company has grown from a startup to a publicly traded billion-dollar enterprise. Her story highlights resilience, innovation, and the power of taking daring risks in biotech success.